1. Home
  2. FSI vs MAIA Comparison

FSI vs MAIA Comparison

Compare FSI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.52

Market Cap

71.3M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.27

Market Cap

77.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
MAIA
Founded
1991
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
77.1M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
FSI
MAIA
Price
$6.52
$1.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.2K
642.7K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
33.33
EPS
0.06
N/A
Revenue
$15,494,325.00
N/A
Revenue This Year
$63.39
N/A
Revenue Next Year
$43.77
N/A
P/E Ratio
$109.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.87
52 Week High
$11.48
$3.19

Technical Indicators

Market Signals
Indicator
FSI
MAIA
Relative Strength Index (RSI) 60.06 42.77
Support Level $6.35 $1.26
Resistance Level $7.40 $1.47
Average True Range (ATR) 0.34 0.10
MACD 0.09 0.01
Stochastic Oscillator 56.52 34.37

Price Performance

Historical Comparison
FSI
MAIA

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: